Alphacalcidol Soft Capsules 1 Microgram

Adult dose

Chronic kidney failure and osteoporosis: Administer 0.5 to 1 ㎍ orally once daily as alphacalcidol. Hypoparathyroidism and other diseases due to vitamin D metabolism abnormalities: Administer 1 to 4 ㎍ orally once daily as this medication.

Child dose

Osteoporosis: Administer 0.01 to 0.03 ㎍ per kg body weight orally once daily as alphacalcidol. Other diseases: Administer 0.05 to 0.1 ㎍ per kg body weight orally once daily as this medication.

This medicine should not be taken by patients with certain electrolyte abnormalities such as hypercalcemia, hyperphosphatemia, or hypermagnesemia. Additionally, patients with a calcium and phosphorus product in the blood above a certain threshold or those with alkalosis should also avoid this medication. Those showing symptoms of vitamin D toxicity or allergic to any component of this medication should refrain from use. It is important not to take magnesium, vitamin D, calcium-containing medications, and certain diuretics concurrently while on this medication. This drug is not recommended for nursing women, and if it must be used, it is advisable to discontinue breastfeeding. Women who are pregnant or may become pregnant should consult a physician before taking this medication, and dosage adjustments and careful monitoring may be necessary for children and the elderly. Patients taking certain medications, such as digitalis, anticonvulsants, or estrogen preparations, should also consult a specialist. Caution is advised for patients with a history of kidney stones or sarcoidosis, and those allergic to any coloring agent included in this drug. If abnormal symptoms occur during administration, discontinue use immediately and consult a physician. Symptoms related to hypercalcemia may include gastrointestinal disturbances, neurological disorders, and decreased kidney function. Regularly monitoring serum calcium levels and kidney function while on this medication is important to prevent adverse effects from overdose. Additionally, regulating calcium intake, and for patients with hyperphosphatemia, taking phosphate binders may be helpful. Immediate treatment is necessary in case of overdose, potentially requiring emergency measures such as inducing vomiting, gastric lavage, or intravenous therapy. Store this medication out of reach of children, protect it from direct sunlight, and keep it in a cool, dry place. To maintain quality, do not transfer to other containers and strictly adhere to the prescribed usage and dosage.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities with cough + fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, lightning headache, seizures, disorientation, visual disturbances, paralysis, urination

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• discomfort in the upper abdomen
• abdominal bloating
• indigestion
• thirst

This medication should be stored in a sealed container that can block light, maintaining a storage temperature between 1 to 30 degrees Celsius. Storing it this way will help preserve its effectiveness and safety.

Appearance

Transparent brown oval soft capsule containing a colorless to pale yellow clear oily substance

Package unit

60 capsules/box [10 capsules/PTP × 6]